Latest News in the pharma Industry

Research & Development

BMS Receives Amended FDA Breakthrough Therapy Designation for Investigational Daclatasvir-Based Hepatitis C Regimen

BMS Receives Amended FDA Breakthrough Therapy Designation for Investigational Daclatasvir-Based Hepatitis C Regimen

26 May 2015

Read more 
Amgen to Terminate Participation in Co-development and Commercialization of Brodalumab

Amgen to Terminate Participation in Co-development and Commercialization of Brodalumab

25 May 2015

Read more 
Otonomy Reports Phase IIb Topline Data for OTO-104 in Meniere's Disease

Otonomy Reports Phase IIb Topline Data for OTO-104 in Meniere's Disease

25 May 2015

Read more 
Isarna Announces Orphan Drug Designation in the EU  for ISTH0036 to Treat Advanced-Stage Glaucoma

Isarna Announces Orphan Drug Designation in the EU for ISTH0036 to Treat Advanced-Stage Glaucoma

21 May 2015

Read more 
Novartis Dug Afinitor Extended Progression-Free Survival in Phase III Trial in Advanced Gastrointestinal or Lung Neuroendocrine Tumours

Novartis Dug Afinitor Extended Progression-Free Survival in Phase III Trial in Advanced Gastrointestinal or Lung Neuroendocrine Tumours

21 May 2015

Read more 
Regeneron and Sanofi Announce Positive Pivotal Phase IIb Dupilumab Data in Asthma

Regeneron and Sanofi Announce Positive Pivotal Phase IIb Dupilumab Data in Asthma

19 May 2015

Read more 
Lilly and Sanford-Burnham Announce Collaboration to Investigate Immunological Therapies

Lilly and Sanford-Burnham Announce Collaboration to Investigate Immunological Therapies

15 May 2015

Read more 
Boehringer Ingelheim Showcases Expanding Presence in Lung Cancer at ASCO

Boehringer Ingelheim Showcases Expanding Presence in Lung Cancer at ASCO

14 May 2015

Read more 
Isarna Presents Positive Preclinical Results Supporting Development of ISTH0036 for the Treatment of Glaucoma

Isarna Presents Positive Preclinical Results Supporting Development of ISTH0036 for the Treatment of Glaucoma

13 May 2015

Read more 
Lilly and BioNTech Announce Research Collaboration on Novel Cancer Immunotherapies

Lilly and BioNTech Announce Research Collaboration on Novel Cancer Immunotherapies

12 May 2015

Read more 
Epigenomics Reaches 99.5% Adherence for Epi proColon in ADMIT Study

Epigenomics Reaches 99.5% Adherence for Epi proColon in ADMIT Study

11 May 2015

Read more 
Near-Atomic Resolution of Protein Structure by Electron Microscopy Holds Promise for Drug Discovery

Near-Atomic Resolution of Protein Structure by Electron Microscopy Holds Promise for Drug Discovery

8 May 2015

Read more